|
| |
Publications
Claudia Fruijtier-Pölloth
Claudia Fruijtier-Pölloth is author of more than 400 quality-reviewed
internal toxicology study reports and author of several publications:
-
Fruijtier-Pölloth, C. (2009).
Alkyl sulphates, alkane sulphanates and alpha-olefin sulphonates. Toxicology
Letters 189, Supplement 1, S4-S5, Abstracts of the 46th Congress
of the European Societies of Toxicology.
-
Fruijtier-Pölloth, C. (2009).
The safety of synthetic zeolites used in detergents. Arch Toxicol. 83(1),
23-25.
-
Fruijtier-Pölloth, C. (2007).
Book review: Nanofabrication towards Biomedical Applications. Regulatory
Affairs Focus, July 2007, p. 7-8.
-
Fruijtier-Pölloth, C. (2005). Safety assessment on polyethylene glycols (PEGs)
and their derivatives as used in cosmetic products. Review Article. Toxicology
214, Issues 1-2, 1-38.
-
Fox, K.K., Cassani, G., Facchi, A., Schroeder, F.R., Pölloth, C., Holt, M.R.
(2002). Measured variations in boron loads reaching European sewage treatment
plants. Chemosphere 47, 499-505.
-
Bishop, W.E. and Pölloth, C. (2000). The Alliance for Chemical Awareness (ACA)
and the Human and Environmental Risk Assessment (HERA) Project: Risk Assessment
and Communication Programs for High Production Volume Chemicals (HPVs). Meeting
Paper, Society for Risk Analysis 2000 Annual Meeting.
-
Scailteur, V., Pölloth, C., Jassogne, Ch. (2000). HERA – Human and
Environmental Risk Assessment Industry Initiative for Chemicals used in
Household Detergent and Cleaning Products. SÖFW Journal, 126(5), 13-15
-
Basketter, D., Hamaide, N., Lichtfus, G., Pölloth, C., Wiebel, F. (2000).
European Labelling Requirements for Skin Sensitisers. European Society of
Contact Dermatitis, Amsterdam 2000.
-
Pölloth C. (2000). Views and Perspectives on Risk Assessment of Detergents and
Cleaning Products. Jorn. Com. Esp. Deterg. 30, Annex, p. 39-46.
-
Pölloth C. et al. (2000). International Multi-Laboratory Validation Study of a
Organotypic Skin Culture as a Preclinical Screen for Cumulative Irritation of
Surfactants. In vitro and Molecular Toxicology.
-
Pölloth, C. and Mangelsdorf, I. (1997). Commentary on the Application of
(Q)SARs to the Toxicological Evaluation of Existing Chemicals. Chemosphere
35/11, p. 2525-2542.
-
Pölloth, C., Remmele, M., Deckardt, K., Schulte, S. (1996). New Screening
Methods in Toxicology: in vitro Tests for Skin and Eye Irritation and Dermal
Penetration. BASF AG, Ludwigshafen/Germany.
-
Jäckh, R., Pölloth, C. and Deckardt, K. (1996). Cytotoxicity Screening:
Extracellular Lactate Levels as Indicator of Functional Toxicity. Abstracts of
the German Society of Pharmacology and Toxicology, 1996.
-
Bahnemann, R., Pölloth, C., Küttler, K., Gans, G., Mellert, W., Kaufmann, W.
(1995). S-phase Response (BrdU-Immunohistochemistry), an Important Tool in the
Evaluation of a Nongenotoxic Carcinogen. Abstract. 2nd International Conference
- Carcinogenesis - New Methods, Interpretation - Risk Assessment. Tours, April
1995.
-
Pölloth, C. (1994). Chapter "Toxicology" in: "Ethylacrylat", BUA Report, VCH
Weinheim.
-
Pölloth, C. (1994). Chapter "Toxicology" in: "Butylacrylat", BUA Report, VCH
Weinheim.
-
Mellert, W., Pölloth, C., Deckardt, K., Gembardt, Ch., Kaufmann, W. (1994).
Effects of N-Allylpyridiniumchloride in vivo and Binding to Cholinergic Receptor
Subtypes in vitro. German Society of Pharmacology and Toxicology.
-
Pölloth, C., Jäckh, R., Sauter, H., Roehl, R. (1992). Cytotoxicity Screening
in Mammalian Cell Cultures. BASF AG, Ludwigshafen/Germany.
-
Pölloth, C. (1989). Spectroscopy Studies in Crown Ether Host Guest Complexes.
University of Ulm/Germany.
-
Pölloth, C. (1988). The Isoelastic Hip Endoprosthesis. Thesis. University of
Ulm/Germany.
Adriaan Fruijtier
-
Fruijtier, A. (2008). Pharmaceutical
Postmarketing and Compliance with the Marketing Authorisation. Update of
Chapter 13 in: Michor, S., Müller, LJ. (eds). 2008 Fundamentals of EU
Regulatory Affairs, RAPS, 147-156.
-
Fruijtier, A. (2008).
Registration Procedures for Medicinal Products: Past, Present and Future.
Update of Chapter 12 in: Michor, S., Müller, LJ. (eds). 2008 Fundamentals of
EU Regulatory Affairs, RAPS, 133-146.
-
Fruijtier, A. (2008).
Overview of Authorisation Procedures for Medicinal Products. Update of
Chapter 2 in: Michor, S., Müller, LJ. (eds), 2008 Fundamentals of EU
Regulatory Affairs, RAPS, 15-26
-
Fruijtier, A. (2007). EMEA/CHMP
Think-Tank Group Report on Innovative Drug Development. Regulatory Affairs
Focus, October 2007, 15-18.
-
Fruijtier, A. (2006).
Pharmaceutical Postmarketing and Compliance with the Marketing
Authorisation. Update of Chapter 12 in: Michor, S., Rowland, K. (eds). 2006
Fundamentals of EU Regulatory Affairs, RAPS, 137-144.
-
Fruijtier, A. (2006).
Registration Procedures for Medicinal Products: Past, Present and Future.
Update of Chapter 11 in: Michor, S., Rowland, K. (eds). 2006 Fundamentals of
EU Regulatory Affairs, RAPS, 125-136.
-
Fruijtier, A. (2006). Overview
of Authorisation Procedures for Medicinal Products and Medical Devices.
Update of Chapter 2 in: Michor, S., Rowland, K. (eds). 2006 Fundamentals of
EU Regulatory Affairs, RAPS, 11-28
-
Fruijtier, A. (2001). Submissions of electronic Marketing
Authorisations (eMAA) in the EU.Good Clinical Practice Journal, Volume 8, No.11.
-
Lindelauf, F., Fruijtier, A. (1995). Gele verkleuring
dihydralazine-infusievloeistof door PVC. Ziekenhuisfarmacie 11:139.
-
Fruijtier, A., Lingeman, H., Beijnen, J. (1990). Derivatization Reactions
and Kinetics in Liquid Chromatography. In Lingeman, H., Underberg W., red.
Detection-Oriented Derivatization Techniques in Liquid Chromatography.New York,
Marcel Dekker, Inc, 51-85.
-
Stolk, L., Fruijtier, A., Wiltink, E. (1986). Stabiliteit retentieklysma met
5-aminosalicylzuur/sulfaguanidine/prednisolonfosfaat. Pharm Weekbl 121:821-2.
-
Stolk, L., Fruijtier, A., Umans, R. (1986). Vincristine oplossing (1 mg/ml)
voor injectie in plastic wegwerpspuitjes: stabiliteit na invriezen bij -20
ºC. Ziekenhuisfarmacie 2:136-7.
-
Stolk, L., Fruijtier, A., Umans, R (1986).
Stability after freezing and thawing of solutions of mitomycin C in plastic
minibags for intravesical use. Pharm Weekbl (Sci) 8:286-8.
|
CATS
Consultants GmbH